Clinical Trials Browser

Uterine Cervical Dysplasia × Vaccines × Gynecologic × Clear all

NCT06243666 2025-07-31

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Active not recruiting

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03629886 2024-03-15

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Phase 4 Completed

6,051 enrolled 11 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04704908 2023-01-26

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04969445 2023-01-26

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05045755 2023-01-26

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Phase 4 Completed

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00988559 2018-07-09

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Phase 1 Completed

132 enrolled 7 charts

Uterine Cervical Dysplasia